United States - English - NLM (National Library of Medicine)

gland pharma limited - caspofungin acetate (unii: vuw370o5qe) (caspofungin - unii:f0xdi6zl63) - caspofungin acetate 5 mg in 1 ml - caspofungin acetate for injection is indicated as empirical therapy for presumed fungal infections in febrile, neutropenic adult and pediatric patients (3 months of age and older) [see clinical studies (14.1,14.5)] . caspofungin acetate for injection is indicated for the treatment of candidemia and the following candida infections: intra-abdominal abscesses, peritonitis, and pleural space infections in adult and pediatric patients (3 months of age and older) [see clinical studies (14.2, 14.5)] . limitations of use : caspofungin acetate for injection has not been studied in endocarditis, osteomyelitis, and meningitis due to candida . caspofungin acetate for injection is indicated for the treatment of esophageal candidiasis in adult and pediatric patients (3 months of age and older) [see clinical studies (14.3,14.5)] . limitations of use : caspofungin acetate for injection has not been approved for the treatment of oropharyngeal candidiasis (opc). in the study that evaluated the efficacy of caspofungin in the

United States - English - NLM (National Library of Medicine)

alvogen inc. - caspofungin acetate (unii: vuw370o5qe) (caspofungin - unii:f0xdi6zl63) - caspofungin acetate 5 mg in 1 ml - caspofungin acetate for injection is indicated as empirical therapy for presumed fungal infections in febrile, neutropenic adult and pediatric patients (3 months of age and older) [see clinical studies (14.1, 14.5)]. caspofungin acetate for injection is indicated for the treatment of candidemia and the following candida infections: intra-abdominal abscesses, peritonitis, and pleural space infections in adult and pediatric patients (3 months of age and older) [see clinical studies (14.2, 14.5)] . limitations of use : caspofungin acetate for injection has not been studied in endocarditis, osteomyelitis, and meningitis due to candida. caspofungin acetate for injection is indicated for the treatment of esophageal candidiasis in adult and pediatric patients (3 months of age and older) [see clinical studies (14.3, 14.5)] . limitations of use : caspofungin acetate for injection has not been approved for the treatment of oropharyngeal candidiasis (opc). in the study that evaluated the efficacy of caspofungin in the

Ireland - English - HPRA (Health Products Regulatory Authority)

cheplapharm arzneimittel gmbh - amphotericin - powder for concentrate for solution for infusion - 50 milligram(s) - antibiotics; amphotericin b

United States - English - NLM (National Library of Medicine)

hainan poly pharm. co., ltd. - voriconazole (unii: jfu09i87tr) (voriconazole - unii:jfu09i87tr) - voriconazole is indicated for use in patients 12 years of age and older in the treatment of the following fungal infections: in clinical trials, the majority of isolates recovered were aspergillus fumigatus . there was a small number of cases of culture-proven disease due to species of aspergillus other than a. fumigatus [ see clinical studies (14.1) and clinical pharmacology (12.4) ]. [ see clinical studies (14.2) and clinical pharmacology (12.4) ] [ see clinical studies (14.3) and clinical pharmacology (12.4) ] [ see clinical studies (14.4) and clinical pharmacology (12.4) ] specimens for fungal culture and other relevant laboratory studies (including histopathology) should be obtained prior to therapy to isolate and identify causative organism(s). therapy may be instituted before the results of the cultures and other laboratory studies are known. however, once these results become available, antifungal therapy should be adjusted accordingly. - voriconazole is contraindicated in patients with k

United States - English - NLM (National Library of Medicine)

ohm pharma inc. - alternaria alternata (unii: 52b29rec7h) (alternaria alternata - unii:52b29rec7h), aspergillus fumigatus (unii: x88df51t48) (aspergillus fumigatus - unii:x88df51t48), aspergillus niger var. niger (unii: 9ioa40ang6) (aspergillus niger var. niger - unii:9ioa40ang6), boletus satanas fruiting body (unii: 68og1407sm) (boletus satanas fruiting body - unii:68og1407sm), botrytis cinerea (unii: tbw53313s7) (botrytis cinerea - unii:tbw53313s7), candida albicans (unii: 4d7g21hdbc) (candida albicans - unii:4d7g21h - uses: temporarily relieves sneezing, runny nose, itchy eyes associated with exposure to molds and fungi.** **claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - alternaria alternata (unii: 52b29rec7h) (alternaria alternata - unii:52b29rec7h), aspergillus niger var. niger (unii: 9ioa40ang6) (aspergillus niger var. niger - unii:9ioa40ang6), candida albicans (unii: 4d7g21hdbc) (candida albicans - unii:4d7g21hdbc), candida parapsilosis (unii: 0kz676d44n) (candida parapsilosis - unii:0kz676d44n), mucor racemosus (unii: 17rh99lq7g) (mucor racemosus - unii:17rh99lq7g), aureobasidium pullulans var. pullutans (unii: d1a2ng69ck) (aureobasidium pullulans var. pullutans - for temporary relief of symptoms related to various forms of candida spp. overgrowth such as nausea, drowsiness, lethargy, confusion, vaginal discharge, sensitivities to foods and mucous congestion.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration. for temporary relief of symptoms related to various forms of candida spp. overgrowth such as nausea, drowsiness, lethargy, confusion, vaginal discharge, sensitivities to foods and mucous congestion.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration.

United States - English - NLM (National Library of Medicine)

dna labs, inc. - alternaria alternata (unii: 52b29rec7h) (alternaria alternata - unii:52b29rec7h), aspergillus niger var. niger (unii: 9ioa40ang6) (aspergillus niger var. niger - unii:9ioa40ang6), cochliobolus spicifer (unii: 91m9rwp3td) (cochliobolus spicifer - unii:91m9rwp3td), gibberella fujikuroi (unii: 815v716or2) (gibberella fujikuroi - unii:815v716or2), cochliobolus sativus (unii: 3ln5b70u4w) (cochliobolus sativus - unii:3ln5b70u4w), cladosporium bruhnei (unii: r1786y8h66) (cladosporium bruhnei - unii:r1786y8h6 - allergies.

United States - English - NLM (National Library of Medicine)

natural creations, inc. - alternaria alternata (unii: 52b29rec7h) (alternaria alternata - unii:52b29rec7h), aspergillus fumigatus (unii: x88df51t48) (aspergillus fumigatus - unii:x88df51t48), botrytis cinerea (unii: tbw53313s7) (botrytis cinerea - unii:tbw53313s7), rhizopus stolonifer (unii: fee198dk4q) (rhizopus stolonifer - unii:fee198dk4q), ustilago maydis (unii: 4k7z7k7swg) (ustilago maydis - unii:4k7z7k7swg) - uses :  temporarily relieves symptoms related to mold allergies.** uses :  temporarily  relieves symptoms related to mold allergies.**

United States - English - NLM (National Library of Medicine)

alk-abello, inc. - alternaria alternata (unii: 52b29rec7h) (alternaria alternata - unii:52b29rec7h), aspergillus fumigatus (unii: x88df51t48) (aspergillus fumigatus - unii:x88df51t48), cladosporium cladosporioides (unii: 4zwy20gtgo) (cladosporium cladosporioides - unii:4zwy20gtgo), penicillium chrysogenum var. chrysogenum (unii: 3y1pe1gcig) (penicillium chrysogenum var. chrysogenum - unii:3y1pe1gcig) - these products are for diagnostic use only. diagnostic allergenic extracts are indicated for use in skin testing to establish the clinical relevance of specific allergens to which the patient has been exposed. by measuring skin test response, the physician may assess the degree of sensitivity that patients have to the allergens. for extracts standardized in au and bau, see individual directions for use. allergenic extracts for diagnostic use only of coffee, mosquito, cottonseed, and flaxseed have not been shown by adequate data to be safe and effective for therapeutic use. patients on beta blockers can be non-responsive to beta agonists that may be required to reverse a systemic reaction (also, see boxed warning statement and adverse reactions ). the physician should carefully weigh the benefit derived from skin testing vs. the risk to the patient should a systemic reaction arise. patients with unstable asthma or steroid dependent asthmatics and patients with underlying cardiovascular disease are at greater

United States - English - NLM (National Library of Medicine)

alk-abello, inc. - alternaria alternata (unii: 52b29rec7h) (alternaria alternata - unii:52b29rec7h), aspergillus fumigatus (unii: x88df51t48) (aspergillus fumigatus - unii:x88df51t48), cladosporium cladosporioides (unii: 4zwy20gtgo) (cladosporium cladosporioides - unii:4zwy20gtgo), penicillium chrysogenum var. chrysogenum (unii: 3y1pe1gcig) (penicillium chrysogenum var. chrysogenum - unii:3y1pe1gcig) - hyposensitization (injection) therapy is a treatment for patients exhibiting allergic reactions to seasonal pollens, dust, molds, animal danders, various other inhalants, and in situations where the offending allergen cannot be avoided. prior to initiation of therapy, the clinical sensitivity should be established by careful evaluation of the patient’s history confirmed by diagnostic skin testing. hyposensitization should not be prescribed for sensitivities to allergens which can easily be avoided. a patient should not be immunized with preparations of allergens to which the patient has not demonstrated symptoms, ige antibodies, positive skin tests, or properly controlled challenge testing. in most cases, immunotherapy is not indicated for those allergens that can be eliminated or minimized by environmental control. patients on beta-blockers are not candidates for immunotherapy, as they can be non-responsive to beta-agonists that may be required to reverse a systemic reaction (also see warnings and adverse